Biotechnology
The Biotechnology industry has a total of 594 stocks, with a combined market cap of $1.16 trillion and total revenue of $110.17 billion.
Market Cap
1.16T
Revenue
110.17B
Profits
-40.04B
PE Ratio
n/a
Profit Margin
-36.34%
Dividend Yield
0.04%
594 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | VRTX | Vertex Pharmaceuticals Incorporated | 109.75B | -0.83% | 501,756 | 12.00B |
| 2 | REGN | Regeneron Pharmaceuticals, Inc. | 76.51B | -2.68% | 400,522 | 14.34B |
| 3 | ARGX | argenx SE | 49.93B | -0.95% | 203,487 | 4.24B |
| 4 | ALNY | Alnylam Pharmaceuticals, Inc. | 40.33B | -3.10% | 345,814 | 3.71B |
| 5 | ONC | BeOne Medicines AG | 33.31B | 0.17% | 83,134 | 5.34B |
| 6 | INSM | Insmed Incorporated | 29.43B | -5.20% | 1,280,153 | 606.42M |
| 7 | RPRX | Royalty Pharma plc | 29.40B | -0.10% | 1,147,335 | 2.38B |
| 8 | RVMD | Revolution Medicines, Inc. | 28.81B | 1.84% | 1,602,639 | - |
| 9 | BNTX | BioNTech SE | 26.63B | -0.23% | 261,991 | 3.37B |
| 10 | MRNA | Moderna, Inc. | 20.23B | -3.48% | 2,574,481 | 1.94B |
| 11 | ROIV | Roivant Sciences Ltd. | 19.81B | -1.62% | 1,890,828 | 13.31M |
| 12 | INCY | Incyte Corporation | 18.91B | -0.48% | 471,864 | 5.14B |
| 13 | SMMT | Summit Therapeutics Inc. | 17.03B | -1.44% | 3,130,821 | - |
| 14 | GMAB | Genmab A/S | 16.77B | 0.13% | 664,128 | 3.72B |
| 15 | BBIO | BridgeBio Pharma, Inc. | 14.28B | 2.75% | 3,220,071 | 502.08M |
| 16 | ASND | Ascendis Pharma A/S | 13.79B | -0.80% | 288,579 | 845.52M |
| 17 | IONS | Ionis Pharmaceuticals, Inc. | 12.10B | -1.16% | 863,833 | 943.71M |
| 18 | JAZZ | Jazz Pharmaceuticals plc | 12.03B | -2.26% | 404,468 | 4.27B |
| 19 | MDGL | Madrigal Pharmaceuticals, Inc. | 11.90B | 0.02% | 118,163 | 958.40M |
| 20 | EXEL | Exelixis, Inc. | 11.44B | -2.16% | 1,157,198 | 2.32B |
| 21 | ARWR | Arrowhead Pharmaceuticals, Inc. | 10.46B | 0.44% | 1,026,396 | 1.09B |
| 22 | BMRN | BioMarin Pharmaceutical Inc. | 10.26B | -1.19% | 513,905 | 3.22B |
| 23 | AXSM | Axsome Therapeutics, Inc. | 9.60B | 2.70% | 191,232 | 638.50M |
| 24 | PRAX | Praxis Precision Medicines, Inc. | 9.43B | 2.72% | 207,016 | 7.46M |
| 25 | ABVX | ABIVAX Société Anonyme | 9.09B | 1.43% | 655,556 | 5.37M |
| 26 | PCVX | Vaxcyte, Inc. | 8.54B | -2.30% | 321,747 | - |
| 27 | TECH | Bio-Techne Corporation | 8.53B | 4.46% | 1,147,282 | 1.22B |
| 28 | NUVL | Nuvalent, Inc. | 8.40B | -1.12% | 480,799 | - |
| 29 | CYTK | Cytokinetics, Incorporated | 8.13B | -0.12% | 439,263 | 88.04M |
| 30 | KRYS | Krystal Biotech, Inc. | 8.05B | 2.05% | 145,904 | 389.13M |
| 31 | IBRX | ImmunityBio, Inc. | 7.85B | -7.20% | 11,991,780 | 113.29M |
| 32 | HALO | Halozyme Therapeutics, Inc. | 7.73B | -2.00% | 492,322 | 1.40B |
| 33 | KYMR | Kymera Therapeutics, Inc. | 7.03B | -1.17% | 182,373 | 39.21M |
| 34 | ACLX | Arcellx, Inc. | 6.75B | -0.01% | 1,252,985 | 22.29M |
| 35 | ERAS | Erasca, Inc. | 6.68B | -4.36% | 4,168,943 | - |
| 36 | PTGX | Protagonist Therapeutics, Inc. | 6.38B | -2.63% | 266,000 | 46.02M |
| 37 | APGE | Apogee Therapeutics, Inc. | 6.37B | -2.31% | 288,427 | - |
| 38 | BLTE | Belite Bio, Inc | 6.30B | -2.55% | 53,663 | - |
| 39 | TERN | Terns Pharmaceuticals, Inc. | 6.10B | 0.09% | 1,728,262 | - |
| 40 | CNTA | Centessa Pharmaceuticals plc | 6.09B | -0.09% | 1,231,616 | 15.00M |
| 41 | SYRE | Spyre Therapeutics, Inc. | 5.99B | 0.27% | 230,792 | - |
| 42 | COGT | Cogent Biosciences, Inc. | 5.93B | 1.91% | 497,365 | - |
| 43 | IMVT | Immunovant, Inc. | 5.87B | -0.21% | 845,017 | - |
| 44 | CGON | CG Oncology, Inc. | 5.83B | -1.27% | 216,106 | 4.04M |
| 45 | CELC | Celcuity Inc. | 5.83B | 6.12% | 685,009 | - |
| 46 | RYTM | Rhythm Pharmaceuticals, Inc. | 5.81B | -0.22% | 128,381 | 189.76M |
| 47 | CAI | Caris Life Sciences, Inc. | 5.67B | 1.36% | 540,593 | 812.03M |
| 48 | PTCT | PTC Therapeutics, Inc. | 5.62B | -0.98% | 288,617 | 1.73B |
| 49 | MIRM | Mirum Pharmaceuticals, Inc. | 5.55B | 0.08% | 159,916 | 521.31M |
| 50 | TGTX | TG Therapeutics, Inc. | 5.43B | -0.46% | 671,199 | 616.29M |
| 51 | SRRK | Scholar Rock Holding Corporation | 5.38B | -1.43% | 684,608 | - |
| 52 | XENE | Xenon Pharmaceuticals Inc. | 5.25B | -0.64% | 306,882 | 7.50M |
| 53 | APLS | Apellis Pharmaceuticals, Inc. | 5.24B | -0.06% | 1,333,740 | 1.00B |
| 54 | CRSP | CRISPR Therapeutics AG | 5.06B | -4.73% | 1,076,055 | 3.51M |
| 55 | CORT | Corcept Therapeutics Incorporated | 4.94B | 2.17% | 275,151 | 761.41M |
| 56 | DNTH | Dianthus Therapeutics, Inc. | 4.79B | -1.99% | 206,205 | 2.04M |
| 57 | FOLD | Amicus Therapeutics, Inc. | 4.55B | 0.24% | 2,903,850 | 634.21M |
| 58 | LGND | Ligand Pharmaceuticals Incorporated | 4.55B | -0.11% | 99,281 | 268.09M |
| 59 | LEGN | Legend Biotech Corporation | 4.47B | 0.83% | 848,615 | 1.03B |
| 60 | CRNX | Crinetics Pharmaceuticals, Inc. | 4.03B | -0.08% | 508,673 | 7.70M |
| 61 | VKTX | Viking Therapeutics, Inc. | 3.83B | 0.85% | 1,136,360 | - |
| 62 | ACAD | ACADIA Pharmaceuticals Inc. | 3.74B | -0.75% | 386,767 | 1.07B |
| 63 | TVTX | Travere Therapeutics, Inc. | 3.72B | -1.25% | 596,481 | 490.73M |
| 64 | TNGX | Tango Therapeutics, Inc. | 3.70B | -0.93% | 3,300,360 | 62.38M |
| 65 | TLX | Telix Pharmaceuticals Limited | 3.62B | 3.53% | 111,359 | 803.79M |
| 66 | NAMS | NewAmsterdam Pharma Company N.V. | 3.47B | -4.20% | 574,197 | 22.50M |
| 67 | ORKA | Oruka Therapeutics, Inc. | 3.40B | -0.04% | 604,003 | - |
| 68 | EWTX | Edgewise Therapeutics, Inc. | 3.38B | 0.99% | 466,884 | - |
| 69 | CPRX | Catalyst Pharmaceuticals, Inc. | 3.34B | -1.23% | 1,224,080 | 588.99M |
| 70 | GPCR | Structure Therapeutics Inc. | 3.24B | -2.86% | 475,669 | - |
| 71 | ALMS | Alumis Inc. | 3.21B | -2.77% | 845,779 | 24.05M |
| 72 | RCUS | Arcus Biosciences, Inc. | 3.21B | 2.03% | 362,204 | 247.00M |
| 73 | DNLI | Denali Therapeutics Inc. | 3.16B | 2.31% | 455,640 | - |
| 74 | DYN | Dyne Therapeutics, Inc. | 3.06B | -2.06% | 572,250 | - |
| 75 | NKTR | Nektar Therapeutics | 2.98B | -1.70% | 481,557 | 55.23M |
| 76 | BEAM | Beam Therapeutics Inc. | 2.93B | -2.98% | 1,354,050 | 139.74M |
| 77 | ARQT | Arcutis Biotherapeutics, Inc. | 2.87B | 1.09% | 540,993 | 376.07M |
| 78 | RLAY | Relay Therapeutics, Inc. | 2.86B | - | 958,693 | 15.36M |
| 79 | KLRA | Kailera Therapeutics, Inc. | 2.85B | -8.13% | 643,677 | - |
| 80 | KOD | Kodiak Sciences Inc. | 2.78B | -0.46% | 241,139 | - |
| 81 | SLNO | Soleno Therapeutics, Inc. | 2.73B | -0.16% | 2,528,397 | 190.41M |
| 82 | IDYA | IDEAYA Biosciences, Inc. | 2.70B | -0.03% | 305,123 | 218.71M |
| 83 | IMNM | Immunome, Inc. | 2.67B | 2.83% | 284,531 | 6.94M |
| 84 | TARS | Tarsus Pharmaceuticals, Inc. | 2.63B | 1.44% | 342,202 | 451.36M |
| 85 | ADMA | ADMA Biologics, Inc. | 2.63B | 2.21% | 2,217,886 | 510.17M |
| 86 | ELVN | Enliven Therapeutics, Inc. | 2.62B | -0.05% | 261,380 | - |
| 87 | VERA | Vera Therapeutics, Inc. | 2.62B | -4.82% | 719,460 | - |
| 88 | IRON | Disc Medicine, Inc. | 2.62B | 0.48% | 128,795 | - |
| 89 | CLDX | Celldex Therapeutics, Inc. | 2.60B | -1.25% | 323,344 | 1.55M |
| 90 | ZLAB | Zai Lab Limited | 2.58B | 5.05% | 228,620 | 460.16M |
| 91 | MANE | Veradermics, Incorporated | 2.48B | -4.08% | 193,201 | - |
| 92 | RARE | Ultragenyx Pharmaceutical Inc. | 2.35B | -1.40% | 518,465 | 673.00M |
| 93 | MLYS | Mineralys Therapeutics, Inc. | 2.31B | -1.58% | 259,917 | - |
| 94 | DFTX | Definium Therapeutics, Inc. | 2.25B | -2.77% | 1,818,052 | - |
| 95 | DAWN | Day One Biopharmaceuticals, Inc. | 2.22B | -0.14% | - | 158.18M |
| 96 | AAPG | Ascentage Pharma Group International | 2.20B | 6.33% | 6,860 | 82.08M |
| 97 | TYRA | Tyra Biosciences, Inc. | 2.19B | 0.53% | 562,696 | - |
| 98 | ADPT | Adaptive Biotechnologies Corporation | 2.17B | 2.03% | 426,003 | 276.98M |
| 99 | SRPT | Sarepta Therapeutics, Inc. | 2.16B | 0.54% | 1,011,865 | 2.20B |
| 100 | AUPH | Aurinia Pharmaceuticals Inc. | 2.13B | -0.62% | 655,619 | 283.06M |
| 101 | ZYME | Zymeworks Inc. | 2.08B | 2.81% | 224,158 | 105.97M |
| 102 | OCUL | Ocular Therapeutix, Inc. | 2.05B | -1.77% | 1,444,024 | 51.95M |
| 103 | MESO | Mesoblast Limited | 2.03B | -0.19% | 41,817 | 65.38M |
| 104 | TRVI | Trevi Therapeutics, Inc. | 2.01B | 1.13% | 457,512 | - |
| 105 | CAPR | Capricor Therapeutics, Inc. | 2.01B | 2.66% | 481,254 | 11.13M |
| 106 | STOK | Stoke Therapeutics, Inc. | 2.00B | -3.03% | 201,509 | 184.42M |
| 107 | GLPG | Galapagos NV | 1.91B | -0.10% | 69,063 | 1.31B |
| 108 | SNDX | Syndax Pharmaceuticals, Inc. | 1.90B | 2.33% | 811,679 | 172.35M |
| 109 | PHVS | Pharvaris N.V. | 1.86B | 4.47% | 118,435 | - |
| 110 | RXRX | Recursion Pharmaceuticals, Inc. | 1.86B | 0.86% | 5,683,150 | 74.68M |
| 111 | TSHA | Taysha Gene Therapies, Inc. | 1.81B | -1.33% | 940,789 | 9.77M |
| 112 | INBX | Inhibrx Biosciences, Inc. | 1.81B | 3.38% | 263,334 | 1.30M |
| 113 | VCEL | Vericel Corporation | 1.80B | 2.85% | 211,300 | 276.26M |
| 114 | HRMY | Harmony Biosciences Holdings, Inc. | 1.78B | -3.87% | 409,241 | 868.45M |
| 115 | PVLA | Palvella Therapeutics, Inc. | 1.76B | -3.35% | 65,603 | - |
| 116 | RAPP | Rapport Therapeutics, Inc. | 1.73B | -0.28% | 143,441 | - |
| 117 | NRIX | Nurix Therapeutics, Inc. | 1.73B | 1.09% | 222,258 | 71.78M |
| 118 | NUVB | Nuvation Bio Inc. | 1.73B | -1.19% | 3,005,871 | 62.90M |
| 119 | INVA | Innoviva, Inc. | 1.73B | -0.47% | 223,665 | 411.33M |
| 120 | ATAI | AtaiBeckley Inc. | 1.71B | -1.89% | 4,292,965 | 4.09M |
| 121 | NTLA | Intellia Therapeutics, Inc. | 1.70B | -9.07% | 4,081,762 | 67.67M |
| 122 | SION | Sionna Therapeutics, Inc. | 1.68B | -2.43% | 339,898 | - |
| 123 | VIR | Vir Biotechnology, Inc. | 1.66B | -0.58% | 680,091 | 68.56M |
| 124 | GENB | Generate Biomedicines, Inc. | 1.64B | -0.08% | 137,534 | 31.89M |
| 125 | NBTX | Nanobiotix S.A. | 1.63B | -0.56% | 53,977 | 38.27M |
| 126 | GLUE | Monte Rosa Therapeutics, Inc. | 1.61B | -0.50% | 235,821 | 123.67M |
| 127 | OCS | Oculis Holding AG | 1.59B | 0.22% | 150,963 | 1.51M |
| 128 | IMTX | Immatics N.V. | 1.52B | 1.97% | 129,280 | 56.67M |
| 129 | MBX | MBX Biosciences, Inc. | 1.51B | -4.79% | 255,389 | - |
| 130 | DMRA | Damora Therapeutics, Inc. | 1.50B | -1.85% | 78,573 | - |
| 131 | BHVN | Biohaven Ltd. | 1.50B | -5.32% | 621,398 | - |
| 132 | BCAX | Bicara Therapeutics Inc. | 1.49B | -0.44% | 170,705 | - |
| 133 | AGIO | Agios Pharmaceuticals, Inc. | 1.49B | -1.38% | 485,412 | 54.03M |
| 134 | IMCR | Immunocore Holdings plc | 1.48B | -0.14% | 107,887 | 400.02M |
| 135 | PGEN | Precigen, Inc. | 1.48B | 5.56% | 2,219,538 | 9.68M |
| 136 | ARDX | Ardelyx, Inc. | 1.46B | -0.17% | 1,058,379 | 407.32M |
| 137 | ANAB | AnaptysBio, Inc. | 1.46B | -1.11% | 159,729 | 234.60M |
| 138 | IOVA | Iovance Biotherapeutics, Inc. | 1.43B | -0.14% | 7,339,880 | 263.50M |
| 139 | MAZE | Maze Therapeutics, Inc. | 1.42B | -1.19% | 249,303 | 2.50M |
| 140 | VRDN | Viridian Therapeutics, Inc. | 1.42B | -3.37% | 490,535 | 70.85M |
| 141 | WVE | Wave Life Sciences Ltd. | 1.38B | -2.19% | 1,370,096 | 42.73M |
| 142 | AVBP | ArriVent BioPharma, Inc. | 1.36B | -0.45% | 305,241 | - |
| 143 | OLMA | Olema Pharmaceuticals, Inc. | 1.35B | 0.85% | 359,801 | - |
| 144 | CRVS | Corvus Pharmaceuticals, Inc. | 1.34B | -0.37% | 840,882 | - |
| 145 | NVAX | Novavax, Inc. | 1.34B | 0.61% | 1,009,429 | 1.12B |
| 146 | MPLT | MapLight Therapeutics, Inc. | 1.32B | 3.13% | 232,211 | - |
| 147 | SVRA | Savara Inc. | 1.31B | 4.55% | 549,728 | - |
| 148 | ABCL | AbCellera Biologics Inc. | 1.27B | 3.83% | 6,618,460 | 75.13M |
| 149 | JBIO | Jade Biosciences, Inc. | 1.24B | -0.44% | 595,565 | - |
| 150 | MLTX | MoonLake Immunotherapeutics | 1.23B | 0.89% | 250,744 | - |
| 151 | GHRS | GH Research PLC | 1.21B | 4.07% | 150,981 | - |
| 152 | PHAR | Pharming Group N.V. | 1.20B | 1.32% | 6,125 | 376.13M |
| 153 | AKTS | Aktis Oncology, Inc. | 1.20B | -2.08% | 154,802 | 6.50M |
| 154 | URGN | UroGen Pharma Ltd. | 1.18B | -0.33% | 298,076 | 109.79M |
| 155 | DBVT | DBV Technologies S.A. | 1.16B | 2.30% | 83,093 | 5.64M |
| 156 | EYPT | EyePoint, Inc. | 1.15B | -0.25% | 346,284 | 31.37M |
| 157 | QURE | uniQure N.V. | 1.12B | 1.37% | 460,538 | 16.10M |
| 158 | SEPN | Septerna, Inc. | 1.12B | -0.32% | 459,003 | 45.95M |
| 159 | ZBIO | Zenas BioPharma, Inc. | 1.10B | -0.22% | 302,950 | 10.00M |
| 160 | IVA | Inventiva S.A. | 1.09B | -0.96% | 202,050 | 7.94M |
| 161 | XERS | Xeris Biopharma Holdings, Inc. | 1.04B | 1.60% | 581,179 | 291.85M |
| 162 | ORIC | ORIC Pharmaceuticals, Inc. | 1.04B | -0.91% | 621,164 | - |
| 163 | KALV | KalVista Pharmaceuticals, Inc. | 1.00B | 2.38% | 491,512 | 73.62M |
| 164 | GERN | Geron Corporation | 970.96M | 1.00% | 8,515,272 | 183.88M |
| 165 | ANNX | Annexon, Inc. | 966.92M | -1.82% | 800,007 | - |
| 166 | XNCR | Xencor, Inc. | 965.87M | 5.78% | 338,794 | 125.58M |
| 167 | CTMX | CytomX Therapeutics, Inc. | 964.38M | -0.45% | 1,243,685 | 76.20M |
| 168 | OMER | Omeros Corporation | 963.31M | -1.04% | 1,138,277 | - |
| 169 | CMPX | Compass Therapeutics, Inc. | 945.46M | 0.77% | 1,814,906 | 850.00K |
| 170 | PHAT | Phathom Pharmaceuticals, Inc. | 936.48M | -3.04% | 989,579 | 175.11M |
| 171 | EVMN | Evommune, Inc. | 924.05M | -0.72% | 123,956 | 13.00M |
| 172 | MRVI | Maravai LifeSciences Holdings, Inc. | 921.59M | 3.91% | 671,408 | 185.74M |
| 173 | JANX | Janux Therapeutics, Inc. | 919.77M | -0.46% | 224,065 | 10.00M |
| 174 | SANA | Sana Biotechnology, Inc. | 919.15M | -2.62% | 1,384,892 | - |
| 175 | FTRE | Fortrea Holdings Inc. | 906.95M | 0.73% | 295,932 | 2.72B |
| 176 | LBRX | LB Pharmaceuticals Inc | 879.67M | -0.32% | 90,049 | - |
| 177 | ANRO | Alto Neuroscience, Inc. | 870.71M | -3.38% | 107,672 | - |
| 178 | DRUG | Bright Minds Biosciences Inc. | 870.01M | -1.17% | 74,716 | - |
| 179 | MGTX | MeiraGTx Holdings plc | 864.48M | 0.21% | 409,063 | 81.39M |
| 180 | MNKD | MannKind Corporation | 841.47M | 0.55% | 1,429,010 | 348.97M |
| 181 | TBPH | Theravance Biopharma, Inc. | 841.39M | 0.18% | 119,084 | 107.46M |
| 182 | KURA | Kura Oncology, Inc. | 824.61M | 0.22% | 408,748 | 67.48M |
| 183 | SPRY | ARS Pharmaceuticals, Inc. | 823.17M | -0.12% | 1,304,205 | 84.28M |
| 184 | CBIO | Crescent Biopharma, Inc. | 819.72M | -3.97% | 156,608 | 10.84M |
| 185 | ABUS | Arbutus Biopharma Corporation | 817.30M | -2.35% | 1,897,219 | 14.08M |
| 186 | SLS | SELLAS Life Sciences Group, Inc. | 806.33M | -3.23% | 5,790,789 | - |
| 187 | CGEM | Cullinan Therapeutics, Inc. | 803.79M | 2.55% | 340,407 | - |
| 188 | ALLO | Allogene Therapeutics, Inc. | 801.47M | -0.85% | 3,778,994 | 22.00K |
| 189 | SGP | SpyGlass Pharma, Inc. | 785.86M | -0.51% | 79,617 | - |
| 190 | DSGN | Design Therapeutics, Inc. | 782.00M | -0.78% | 169,259 | - |
| 191 | VOR | Vor Biopharma Inc. | 781.36M | -1.37% | 499,477 | - |
| 192 | SLDB | Solid Biosciences Inc. | 778.30M | -3.77% | 446,331 | - |
| 193 | RLMD | Relmada Therapeutics, Inc. | 753.10M | -0.97% | 400,074 | - |
| 194 | TENX | Tenax Therapeutics, Inc. | 723.82M | 3.01% | 152,172 | - |
| 195 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 714.29M | -0.50% | 306,092 | - |
| 196 | LXRX | Lexicon Pharmaceuticals, Inc. | 709.67M | -0.30% | 1,563,403 | 49.80M |
| 197 | DRTS | Alpha Tau Medical Ltd. | 702.76M | 0.06% | 203,883 | - |
| 198 | FBRX | Forte Biosciences, Inc. | 689.80M | -2.36% | 105,941 | - |
| 199 | GYRE | Gyre Therapeutics, Inc. | 683.94M | 0.67% | 18,695 | 116.59M |
| 200 | TRAX | First Tracks Biotherapeutics, Inc. | 671.70M | 1.74% | 383,200 | - |
| 201 | PRME | Prime Medicine, Inc. | 662.28M | -2.60% | 835,377 | 4.63M |
| 202 | ARVN | Arvinas, Inc. | 660.72M | -0.86% | 275,142 | 262.60M |
| 203 | ZVRA | Zevra Therapeutics, Inc. | 595.88M | -0.30% | 437,323 | 106.47M |
| 204 | ACRS | Aclaris Therapeutics, Inc. | 594.90M | -5.93% | 1,072,801 | 7.83M |
| 205 | PROK | ProKidney Corp. | 594.86M | -1.50% | 583,755 | 893.00K |
| 206 | ABSI | Absci Corporation | 594.49M | -2.14% | 2,585,417 | 2.80M |
| 207 | ANL | Adlai Nortye Ltd. | 582.80M | -2.28% | 176,993 | 5.00M |
| 208 | STTK | Shattuck Labs, Inc. | 581.22M | 0.52% | 139,010 | 1.00M |
| 209 | PRTA | Prothena Corporation plc | 579.78M | 0.37% | 133,166 | 9.68M |
| 210 | CRMD | CorMedix Inc. | 576.45M | 0.27% | 300,052 | 311.71M |
| 211 | KYTX | Kyverna Therapeutics, Inc. | 572.01M | 5.59% | 1,040,287 | - |
| 212 | OCGN | Ocugen, Inc. | 558.55M | -1.20% | 4,475,459 | 4.41M |
| 213 | RIGL | Rigel Pharmaceuticals, Inc. | 558.10M | -1.69% | 205,135 | 294.28M |
| 214 | LYEL | Lyell Immunopharma, Inc. | 551.72M | 0.21% | 20,280 | 36.00K |
| 215 | ENGN | enGene Therapeutics Inc. | 539.27M | -1.11% | 141,391 | - |
| 216 | STRO | Sutro Biopharma, Inc. | 538.10M | -6.75% | 199,619 | 102.48M |
| 217 | IMMX | Immix Biopharma, Inc. | 535.42M | -0.69% | 258,557 | - |
| 218 | TECX | Tectonic Therapeutic, Inc. | 534.20M | 0.04% | 137,064 | - |
| 219 | EIKN | Eikon Therapeutics, Inc. | 531.10M | -8.32% | 90,418 | - |
| 220 | AGMB | AgomAb Therapeutics NV | 529.28M | 1.50% | 51,492 | - |
| 221 | FULC | Fulcrum Therapeutics, Inc. | 520.81M | -3.22% | 429,736 | 80.00M |
| 222 | VSTM | Verastem, Inc. | 520.03M | -4.98% | 994,114 | 30.91M |
| 223 | UPB | Upstream Bio, Inc. | 519.17M | -0.63% | 222,996 | 2.85M |
| 224 | MDXG | MiMedx Group, Inc. | 518.50M | 4.18% | 824,270 | 418.63M |
| 225 | ZURA | Zura Bio Limited | 507.61M | -3.08% | 370,407 | - |
| 226 | ADCT | ADC Therapeutics SA | 504.94M | 0.25% | 540,903 | 81.36M |
| 227 | ARMP | Armata Pharmaceuticals, Inc. | 485.38M | -2.07% | 21,085 | 4.90M |
| 228 | FDMT | 4D Molecular Therapeutics, Inc. | 481.93M | -1.77% | 226,984 | 85.21M |
| 229 | AURA | Aura Biosciences, Inc. | 479.85M | 3.03% | 157,949 | - |
| 230 | CADL | Candel Therapeutics, Inc. | 475.37M | -7.81% | 1,228,657 | - |
| 231 | VALN | Valneva SE | 470.89M | 1.97% | 120,717 | 205.07M |
| 232 | PRLD | Prelude Therapeutics Incorporated | 469.58M | 6.14% | 586,698 | 12.14M |
| 233 | LRMR | Larimar Therapeutics, Inc. | 469.03M | 0.33% | 522,432 | - |
| 234 | CTNM | Contineum Therapeutics, Inc. | 463.53M | -0.04% | 86,026 | - |
| 235 | DNA | Ginkgo Bioworks Holdings, Inc. | 462.17M | 3.12% | 308,180 | 170.16M |
| 236 | RGNX | REGENXBIO Inc. | 454.23M | -2.11% | 400,272 | 170.44M |
| 237 | TRDA | Entrada Therapeutics, Inc. | 452.88M | -1.80% | 78,087 | 25.42M |
| 238 | XOMA | XOMA Royalty Corporation | 452.34M | 0.19% | 43,741 | 52.15M |
| 239 | EPRX | Eupraxia Pharmaceuticals Inc. | 449.08M | 1.17% | 74,405 | - |
| 240 | ASMB | Assembly Biosciences, Inc. | 445.58M | -0.85% | 23,088 | 72.30M |
| 241 | AVIR | Atea Pharmaceuticals, Inc. | 436.60M | -0.72% | 106,293 | - |
| 242 | LXEO | Lexeo Therapeutics, Inc. | 434.15M | -2.50% | 586,851 | - |
| 243 | BNTC | Benitec Biopharma Inc. | 429.39M | -1.30% | 85,254 | - |
| 244 | CLYM | Climb Bio, Inc. | 428.72M | -0.50% | 170,368 | - |
| 245 | NGNE | Neurogene Inc. | 422.41M | 0.37% | 97,292 | 925.00K |
| 246 | IVVD | Invivyd, Inc. | 419.96M | -1.66% | 975,185 | 53.43M |
| 247 | PRTC | PureTech Health plc | 413.57M | 1.35% | 7,004 | 6.39M |
| 248 | NMRA | Neumora Therapeutics, Inc. | 411.96M | 1.12% | 476,044 | - |
| 249 | VTVT | vTv Therapeutics Inc. | 410.01M | -5.19% | 100,463 | 17.00K |
| 250 | IPSC | Century Therapeutics, Inc. | 407.83M | 0.22% | 505,565 | 109.16M |
| 251 | VNDA | Vanda Pharmaceuticals Inc. | 404.89M | 2.39% | 559,271 | 216.11M |
| 252 | NAGE | Niagen Bioscience, Inc. | 394.02M | 3.81% | 277,826 | 129.42M |
| 253 | IMRX | Immuneering Corporation | 392.44M | -0.98% | 440,414 | - |
| 254 | AUTL | Autolus Therapeutics plc | 391.23M | -3.92% | 811,439 | 75.39M |
| 255 | LCTX | Lineage Cell Therapeutics, Inc. | 391.07M | 0.64% | 566,444 | 14.56M |
| 256 | RCKT | Rocket Pharmaceuticals, Inc. | 389.02M | -3.13% | 920,285 | - |
| 257 | ENTA | Enanta Pharmaceuticals, Inc. | 387.55M | 0.04% | 69,736 | 66.98M |
| 258 | XFOR | X4 Pharmaceuticals, Inc. | 381.86M | -1.87% | 355,468 | 35.11M |
| 259 | PBYI | Puma Biotechnology, Inc. | 379.54M | 0.81% | 106,998 | 228.37M |
| 260 | ALT | Altimmune, Inc. | 375.35M | -0.17% | 8,393,908 | 41.00K |
| 261 | IRD | Opus Genetics, Inc. | 374.96M | 1.15% | 480,869 | 14.20M |
| 262 | YDES | YD Bio Limited | 374.80M | 1.62% | 4,044 | 510.36K |
| 263 | AVTX | Avalo Therapeutics, Inc. | 367.59M | -6.71% | 302,215 | 59.00K |
| 264 | SLN | Silence Therapeutics plc | 365.12M | -1.40% | 495,042 | 559.00K |
| 265 | PALI | Palisade Bio, Inc. | 357.45M | -1.61% | 3,678,405 | - |
| 266 | MNPR | Monopar Therapeutics Inc. | 352.21M | -1.15% | 123,398 | - |
| 267 | OVID | Ovid Therapeutics Inc. | 348.15M | -1.49% | 727,255 | 7.25M |
| 268 | GLSI | Greenwich LifeSciences, Inc. | 341.03M | 3.99% | 71,749 | - |
| 269 | DMAC | DiaMedica Therapeutics Inc. | 338.92M | 1.13% | 60,850 | - |
| 270 | BCYC | Bicycle Therapeutics plc | 338.78M | 0.21% | 230,212 | 72.59M |
| 271 | NAUT | Nautilus Biotechnology, Inc. | 337.93M | 3.49% | 202,092 | - |
| 272 | SRZN | Surrozen, Inc. | 331.62M | -5.76% | 54,122 | 3.48M |
| 273 | CABA | Cabaletta Bio, Inc. | 328.40M | -3.28% | 1,315,216 | - |
| 274 | IKT | Inhibikase Therapeutics, Inc. | 326.42M | -0.78% | 302,116 | 1.00 |
| 275 | RZLT | Rezolute, Inc. | 319.93M | -0.96% | 611,619 | - |
| 276 | NGEN | NervGen Pharma Corp. | 317.25M | -0.25% | 91,975 | - |
| 277 | FHTX | Foghorn Therapeutics Inc. | 312.29M | 2.50% | 38,967 | 30.91M |
| 278 | AVXL | Anavex Life Sciences Corp. | 311.84M | 1.66% | 343,499 | - |
| 279 | ABEO | Abeona Therapeutics Inc. | 306.88M | -2.26% | 496,803 | 5.82M |
| 280 | NERV | Minerva Neurosciences, Inc. | 296.37M | -1.02% | 101,859 | - |
| 281 | CGEN | Compugen Ltd. | 294.54M | 6.68% | 1,086,350 | 72.76M |
| 282 | LENZ | LENZ Therapeutics, Inc. | 293.48M | 2.30% | 376,895 | 19.09M |
| 283 | EDIT | Editas Medicine, Inc. | 292.64M | -6.85% | 888,992 | 40.52M |
| 284 | NBP | NovaBridge Biosciences | 288.54M | 1.01% | 265,157 | - |
| 285 | ZNTL | Zentalis Pharmaceuticals, Inc. | 286.92M | 3.98% | 585,679 | 26.87M |
| 286 | ACIU | AC Immune SA | 285.70M | -3.03% | 88,176 | 4.51M |
| 287 | CLLS | Cellectis S.A. | 284.00M | 1.79% | 6,663 | 79.59M |
| 288 | TARA | Protara Therapeutics, Inc. | 283.94M | -0.19% | 210,206 | - |
| 289 | CCCC | C4 Therapeutics, Inc. | 282.98M | -2.36% | 1,773,263 | 35.95M |
| 290 | HELP | Cybin Inc. | 281.20M | -2.26% | 1,397,454 | - |
| 291 | ALEC | Alector, Inc. | 269.51M | 0.49% | 169,583 | 21.05M |
| 292 | CHRS | Coherus Oncology, Inc. | 269.11M | -0.85% | 705,552 | 42.17M |
| 293 | ARTV | Artiva Biotherapeutics, Inc. | 267.93M | -4.07% | 85,946 | 251.00K |
| 294 | ELDN | Eledon Pharmaceuticals, Inc. | 262.08M | -3.90% | 1,315,254 | - |
| 295 | SABS | SAB Biotherapeutics, Inc. | 256.15M | -4.08% | 385,351 | 114.70K |
| 296 | ARCT | Arcturus Therapeutics Holdings Inc. | 246.71M | 2.48% | 179,006 | 82.03M |
| 297 | SLGL | Sol-Gel Technologies Ltd. | 243.74M | 3.13% | 34,442 | 19.39M |
| 298 | ADAG | Adagene Inc. | 243.48M | -1.47% | 64,189 | 7.67M |
| 299 | OBIO | Orchestra BioMed Holdings, Inc. | 243.15M | 0.12% | 191,990 | 33.48M |
| 300 | FENC | Fennec Pharmaceuticals Inc. | 240.12M | 4.58% | 55,320 | 44.64M |
| 301 | NVCT | Nuvectis Pharma, Inc. | 238.16M | 2.28% | 50,141 | - |
| 302 | CDXS | Codexis, Inc. | 237.17M | 3.57% | 1,153,811 | 70.39M |
| 303 | PLYX | Polaryx Therapeutics, Inc. | 236.72M | -6.02% | 68,124 | - |
| 304 | MIST | Milestone Pharmaceuticals Inc. | 234.87M | 2.41% | 545,251 | 1.55M |
| 305 | VYGR | Voyager Therapeutics, Inc. | 231.54M | -3.84% | 308,438 | 40.37M |
| 306 | KROS | Keros Therapeutics, Inc. | 227.93M | - | 116,750 | 244.06M |
| 307 | CAMP | Camp4 Therapeutics Corporation | 221.18M | -4.05% | 29,393 | 3.50M |
| 308 | ELTX | Elicio Therapeutics, Inc. | 219.65M | 0.76% | 53,019 | - |
| 309 | ALXO | ALX Oncology Holdings Inc. | 217.15M | 3.77% | 377,873 | - |
| 310 | ACHV | Achieve Life Sciences, Inc. | 215.09M | -2.65% | 585,959 | - |
| 311 | MDWD | MediWound Ltd. | 214.38M | 0.18% | 28,611 | 16.96M |
| 312 | ENLV | Enlivex Ltd. | 212.98M | -1.05% | 191,672 | - |
| 313 | OABI | OmniAb, Inc. | 212.11M | -6.09% | 327,959 | 18.67M |
| 314 | CRBU | Caribou Biosciences, Inc. | 210.67M | -3.54% | 1,109,932 | 11.16M |
| 315 | NKTX | Nkarta, Inc. | 209.59M | -1.34% | 479,322 | - |
| 316 | CNTX | Context Therapeutics Inc. | 207.65M | -2.59% | 1,285,963 | - |
| 317 | MGNX | MacroGenics, Inc. | 204.66M | 1.26% | 371,112 | 149.50M |
| 318 | HRTX | Heron Therapeutics, Inc. | 203.62M | 8.02% | 2,279,822 | 154.90M |
| 319 | REPL | Replimune Group, Inc. | 199.00M | -15.44% | 6,719,869 | - |
| 320 | KPTI | Karyopharm Therapeutics Inc. | 195.23M | -1.03% | 192,088 | 146.07M |
| 321 | SGMT | Sagimet Biosciences Inc. | 192.90M | 0.85% | 192,086 | - |
| 322 | CNTN | Canton Strategic Holdings, Inc. | 192.63M | 0.89% | 214,987 | - |
| 323 | KRRO | Korro Bio, Inc. | 191.03M | -2.57% | 72,524 | 6.39M |
| 324 | ABOS | Acumen Pharmaceuticals, Inc. | 191.00M | -0.94% | 316,656 | - |
| 325 | WHWK | Whitehawk Therapeutics, Inc. | 190.67M | -3.12% | 87,747 | 7.15M |
| 326 | UNCY | Unicycive Therapeutics, Inc. | 183.48M | -1.09% | 193,806 | - |
| 327 | RNAC | Cartesian Therapeutics, Inc. | 182.91M | -1.00% | 77,157 | 2.80M |
| 328 | DTIL | Precision BioSciences, Inc. | 182.69M | -3.15% | 130,715 | 34.26M |
| 329 | TNXP | Tonix Pharmaceuticals Holding Corp. | 179.70M | 1.28% | 171,412 | 13.11M |
| 330 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | 177.10M | -2.30% | 147,902 | - |
| 331 | PLX | Protalix BioTherapeutics, Inc. | 175.24M | 1.64% | 294,799 | 52.74M |
| 332 | BDTX | Black Diamond Therapeutics, Inc. | 170.43M | -4.03% | 826,989 | 70.00M |
| 333 | MENS | Jyong Biotech Ltd. | 169.18M | -3.08% | 32,049 | - |
| 334 | PRQR | ProQR Therapeutics N.V. | 167.52M | -2.45% | 562,151 | 19.19M |
| 335 | SPRO | Spero Therapeutics, Inc. | 160.65M | -0.89% | 241,471 | 66.80M |
| 336 | TLSA | Tiziana Life Sciences Ltd | 158.25M | 0.81% | 86,556 | - |
| 337 | HUMA | Humacyte, Inc. | 157.74M | 0.34% | 1,461,107 | 2.04M |
| 338 | GALT | Galectin Therapeutics Inc. | 156.34M | 0.21% | 122,571 | - |
| 339 | MOLN | Molecular Partners AG | 155.64M | 1.36% | 806 | 856.30K |
| 340 | ORMP | Oramed Pharmaceuticals Inc. | 155.11M | -0.13% | 32,373 | 2.00M |
| 341 | FATE | Fate Therapeutics, Inc. | 154.63M | 0.76% | 582,319 | 6.65M |
| 342 | ANTX | AN2 Therapeutics, Inc. | 154.06M | - | 140,705 | - |
| 343 | ACOG | Alpha Cognition Inc. | 152.20M | 2.04% | 17,876 | 10.22M |
| 344 | TNYA | Tenaya Therapeutics, Inc. | 151.90M | 2.35% | 1,462,344 | - |
| 345 | AGEN | Agenus Inc. | 151.29M | 4.79% | 458,762 | 114.20M |
| 346 | SPRB | Spruce Biosciences, Inc. | 150.90M | 3.39% | 42,065 | 697.00K |
| 347 | HURA | TuHURA Biosciences, Inc. | 150.05M | 3.06% | 754,692 | - |
| 348 | ALPS | Alps Group Inc | 149.78M | -1.63% | 3,006 | 3.74M |
| 349 | CNTB | Connect Biopharma Holdings Limited | 144.13M | 1.19% | 92,387 | 64.00K |
| 350 | KZIA | Kazia Therapeutics Limited | 140.78M | 4.23% | 123,463 | 1.27M |
| 351 | KLRS | Kalaris Therapeutics, Inc. | 140.17M | 0.22% | 14,209 | - |
| 352 | BMEA | Biomea Fusion, Inc. | 139.18M | 2.94% | 954,048 | - |
| 353 | EQ | Equillium, Inc. | 136.25M | -0.69% | 253,267 | 4.39M |
| 354 | KALA | KALA BIO, Inc. | 132.92M | -7.14% | 5,374,855 | - |
| 355 | IPHA | Innate Pharma S.A. | 126.83M | 2.19% | 18,954 | 10.57M |
| 356 | PYXS | Pyxis Oncology, Inc. | 123.46M | 14.91% | 573,097 | 13.86M |
| 357 | NTHI | NeOnc Technologies Holdings, Inc. | 118.83M | -0.42% | 86,236 | 39.99K |
| 358 | IMUX | Immunic, Inc. | 117.37M | -2.04% | 2,465,702 | - |
| 359 | ONCY | Oncolytics Biotech Inc. | 117.29M | -7.34% | 785,081 | - |
| 360 | AARD | Aardvark Therapeutics, Inc. | 116.93M | -0.19% | 75,557 | - |
| 361 | CRDF | Cardiff Oncology, Inc. | 116.90M | 2.40% | 285,660 | 593.00K |
| 362 | VRCA | Verrica Pharmaceuticals Inc. | 115.53M | 3.62% | 73,729 | 35.58M |
| 363 | CGTX | Cognition Therapeutics, Inc. | 115.18M | 2.30% | 568,879 | - |
| 364 | CBUS | Cibus, Inc. | 114.42M | 3.45% | 217,115 | 3.64M |
| 365 | VANI | Vivani Medical, Inc. | 113.85M | 2.67% | 172,841 | - |
| 366 | SEER | Seer, Inc. | 112.28M | 2.58% | 1,031,740 | 16.58M |
| 367 | GNLX | Genelux Corporation | 111.66M | -0.14% | 98,433 | 8.00K |
| 368 | IFRX | InflaRx N.V. | 110.61M | -1.92% | 846,222 | 34.44K |
| 369 | PEPG | PepGen Inc. | 106.78M | -2.83% | 248,208 | - |
| 370 | COEP | Coeptis Therapeutics Holdings, Inc. | 105.79M | 4.87% | 77,651 | 1.36M |
| 371 | TTRX | Turn Therapeutics Inc. | 104.11M | 4.33% | 13,055 | - |
| 372 | ANIX | Anixa Biosciences, Inc. | 102.60M | 0.66% | 44,625 | - |
| 373 | COYA | Coya Therapeutics, Inc. | 101.57M | -0.23% | 72,996 | 7.95M |
| 374 | PMN | ProMIS Neurosciences, Inc. | 99.77M | 2.25% | 20,020 | - |
| 375 | GUTS | Fractyl Health, Inc. | 98.51M | 6.87% | 1,589,832 | 3.00K |
| 376 | NRXP | NRx Pharmaceuticals, Inc. | 97.78M | 4.23% | 351,778 | 1.23M |
| 377 | ALDX | Aldeyra Therapeutics, Inc. | 93.89M | -2.50% | 1,025,677 | - |
| 378 | INO | Inovio Pharmaceuticals, Inc. | 93.82M | 0.44% | 512,123 | 65.34K |
| 379 | RANI | Rani Therapeutics Holdings, Inc. | 92.72M | 1.46% | 380,682 | 1.63M |
| 380 | QTTB | Q32 Bio Inc. | 91.87M | -3.09% | 184,425 | 53.74M |
| 381 | NRXS | NeurAxis, Inc. | 90.28M | 8.32% | 416,729 | 3.57M |
| 382 | PYPD | PolyPid Ltd. | 88.16M | -0.43% | 18,210 | - |
| 383 | EXOZ | eXoZymes, Inc. | 87.42M | -0.10% | 456 | -700.00 |
| 384 | GOSS | Gossamer Bio, Inc. | 86.34M | -1.53% | 2,140,056 | 48.47M |
| 385 | ACET | Adicet Bio, Inc. | 85.51M | 0.70% | 33,269 | - |
| 386 | GANX | Gain Therapeutics, Inc. | 85.12M | 6.61% | 584,769 | - |
| 387 | OKYO | OKYO Pharma Limited | 84.49M | 1.26% | 18,423 | - |
| 388 | CSBR | Champions Oncology, Inc. | 80.54M | -3.97% | 1,081 | 57.95M |
| 389 | FLNA | Filana Therapeutics, Inc. | 79.95M | -0.30% | 100,971 | - |
| 390 | LONA | LeonaBio, Inc. | 79.56M | -1.74% | 37,237 | - |
| 391 | MAIA | MAIA Biotechnology, Inc. | 79.48M | 3.97% | 298,522 | - |
| 392 | ATYR | aTyr Pharma, Inc. | 78.44M | 1.05% | 470,064 | 190.00K |
| 393 | ATHE | Alterity Therapeutics Limited | 77.89M | 2.52% | 5,666 | 4.43M |
| 394 | XBIT | XBiotech Inc. | 77.74M | 0.79% | 8,073 | - |
| 395 | PTHS | Pelthos Therapeutics Inc. | 77.11M | -0.95% | 11,648 | 16.80M |
| 396 | PLRX | Pliant Therapeutics, Inc. | 77.08M | -1.19% | 232,886 | - |
| 397 | PMVP | PMV Pharmaceuticals, Inc. | 77.06M | 1.05% | 229,357 | - |
| 398 | MCRB | Seres Therapeutics, Inc. | 76.69M | -1.11% | 53,981 | 789.00K |
| 399 | ICCC | ImmuCell Corporation | 75.77M | 4.69% | 15,945 | 27.64M |
| 400 | ACRV | Acrivon Therapeutics, Inc. | 75.75M | 3.44% | 289,437 | - |
| 401 | SGMO | Sangamo Therapeutics, Inc. | 75.69M | -28.35% | 21,163,828 | 39.55M |
| 402 | TCRX | TScan Therapeutics, Inc. | 74.83M | 3.75% | 625,998 | 10.33M |
| 403 | IMMP | Immutep Limited | 73.88M | 0.05% | 1,596,249 | 5.28M |
| 404 | FBIO | Fortress Biotech, Inc. | 73.74M | 2.69% | 130,715 | 63.26M |
| 405 | OSTX | OS Therapies Incorporated | 73.15M | 20.00% | 2,339,024 | - |
| 406 | BYSI | BeyondSpring Inc. | 70.11M | 2.71% | 2,697 | 1.88M |
| 407 | ACTU | Actuate Therapeutics, Inc. | 69.00M | 15.02% | 98,613 | - |
| 408 | IBO | Impact BioMedical Inc. | 68.99M | -2.31% | 15,799 | 32.00K |
| 409 | IMA | ImageneBio, Inc. | 68.51M | 4.52% | 14,165 | 800.00K |
| 410 | MNOV | MediciNova, Inc. | 66.94M | -0.73% | 12,099 | 409.66K |
| 411 | ESLA | Estrella Immunopharma, Inc. | 66.77M | -8.48% | 89,156 | - |
| 412 | OKUR | OnKure Therapeutics, Inc. | 66.04M | -1.43% | 44,674 | - |
| 413 | CING | Cingulate Inc. | 64.07M | -1.96% | 279,043 | - |
| 414 | IBIO | iBio, Inc. | 62.53M | -4.42% | 797,715 | 300.00K |
| 415 | EDSA | Edesa Biotech, Inc. | 62.20M | 3.24% | 52,800 | - |
| 416 | ANVS | Annovis Bio, Inc. | 62.16M | -0.55% | 530,461 | - |
| 417 | HYFT | MindWalk Holdings Corp. | 61.83M | 3.75% | 134,920 | 20.70M |
| 418 | CUE | Cue Biopharma, Inc. | 54.95M | 1.53% | 261,801 | 27.47M |
| 419 | MGX | Metagenomi Therapeutics, Inc. | 54.93M | 2.10% | 49,257 | 25.21M |
| 420 | KZR | Kezar Life Sciences, Inc. | 54.08M | 0.69% | 30,450 | - |
| 421 | TIL | Instil Bio, Inc. | 53.98M | -2.69% | 16,284 | - |
| 422 | INKT | MiNK Therapeutics, Inc. | 53.23M | -0.09% | 31,392 | - |
| 423 | ENTX | Entera Bio Ltd. | 52.68M | -3.42% | 50,893 | 42.00K |
| 424 | PDSB | PDS Biotechnology Corporation | 51.91M | 0.20% | 743,471 | - |
| 425 | RADX | Radiopharm Theranostics Limited | 50.77M | -1.44% | 17,236 | 10.86M |
| 426 | ATOS | Atossa Therapeutics, Inc. | 48.86M | -0.97% | 39,264 | - |
| 427 | TELO | Telomir Pharmaceuticals, Inc. | 48.82M | 2.90% | 38,600 | - |
| 428 | XLO | Xilio Therapeutics, Inc. | 48.80M | -0.35% | 26,692 | 43.77M |
| 429 | NTRB | Nutriband Inc. | 48.44M | -0.62% | 2,105 | 2.28M |
| 430 | RNTX | Rein Therapeutics Inc. | 47.67M | -7.61% | 91,171 | - |
| 431 | HYPD | Hyperion DeFi, Inc. | 46.36M | 3.56% | 113,334 | 813.46K |
| 432 | MREO | Mereo BioPharma Group plc | 46.29M | -5.41% | 814,259 | 500.00K |
| 433 | PSTV | Plus Therapeutics, Inc. | 45.29M | -9.34% | 150,686 | 5.21M |
| 434 | DWTX | Dogwood Therapeutics, Inc. | 45.09M | -3.57% | 106,302 | - |
| 435 | RLYB | Rallybio Corporation | 44.96M | - | 13,188 | 858.00K |
| 436 | LIXT | Lixte Biotechnology Holdings, Inc. | 44.15M | -4.52% | 44,258 | - |
| 437 | SNSE | Sensei Biotherapeutics, Inc. | 42.23M | -3.40% | 4,633 | - |
| 438 | LITS | Lite Strategy, Inc. | 42.18M | -1.69% | 294,758 | - |
| 439 | ATRA | Atara Biotherapeutics, Inc. | 41.01M | 2.35% | 20,641 | 120.77M |
| 440 | ALGS | Aligos Therapeutics, Inc. | 40.41M | 6.53% | 124,829 | 2.19M |
| 441 | HOWL | Werewolf Therapeutics, Inc. | 40.02M | -4.25% | 110,993 | 1.14M |
| 442 | RNXT | RenovoRx, Inc. | 39.87M | -1.67% | 208,797 | 1.12M |
| 443 | ATNM | Actinium Pharmaceuticals, Inc. | 39.59M | -3.05% | 141,228 | 90.00K |
| 444 | INMB | INmune Bio Inc. | 37.49M | 2.17% | 101,959 | 50.00K |
| 445 | VERU | Veru Inc. | 37.35M | 0.74% | 14,146 | 16.89M |
| 446 | PTN | Palatin Technologies, Inc. | 36.33M | 3.26% | 4,628 | 8.96M |
| 447 | CRVO | CervoMed Inc. | 35.74M | 0.26% | 25,232 | 4.01M |
| 448 | NXTC | NextCure, Inc. | 35.60M | -19.35% | 53,443 | - |
| 449 | BOLD | Boundless Bio, Inc. | 34.51M | 1.32% | 81,113 | - |
| 450 | GRCE | Grace Therapeutics, Inc. | 34.51M | -5.11% | 2,872,528 | - |
| 451 | IGC | IGC Pharma, Inc. | 33.51M | -0.14% | 307,619 | 1.11M |
| 452 | SNTI | Senti Biosciences, Inc. | 33.32M | 5.94% | 118,465 | 22.00K |
| 453 | EVAX | Evaxion A/S | 33.19M | -6.35% | 30,383 | 7.53M |
| 454 | OTLK | Outlook Therapeutics, Inc. | 33.08M | 10.21% | 2,999,006 | 205.70K |
| 455 | PLUR | Pluri Inc. | 32.53M | -5.91% | 7,487 | 1.34M |
| 456 | SKYE | Skye Bioscience, Inc. | 32.40M | 2.63% | 113,095 | - |
| 457 | CELU | Celularity Inc. | 31.43M | -2.68% | 20,219 | 40.58M |
| 458 | DYAI | Dyadic International, Inc. | 31.34M | -0.69% | 9,071 | 3.09M |
| 459 | DARE | Daré Bioscience, Inc. | 30.87M | - | 284,816 | 1.03M |
| 460 | TVGN | Tevogen Bio Holdings Inc. | 30.61M | 4.85% | 8,873 | - |
| 461 | TVRD | Tvardi Therapeutics, Inc. | 29.46M | 4.32% | 8,349 | - |
| 462 | KYNB | Kyntra Bio, Inc. | 28.98M | 2.13% | 8,348 | 6.44M |
| 463 | LSTA | Lisata Therapeutics, Inc. | 28.90M | -3.90% | 23,464 | 170.00K |
| 464 | APLM | Apollomics, Inc. | 28.52M | 0.32% | 1,440 | 6.93M |
| 465 | LGVN | Longeveron Inc. | 28.08M | -1.77% | 126,496 | 1.20M |
| 466 | LTRN | Lantern Pharma Inc. | 27.91M | 7.79% | 151,135 | - |
| 467 | ABVC | ABVC BioPharma, Inc. | 27.18M | -3.51% | 84,257 | 797.92K |
| 468 | BCTX | BriaCell Therapeutics Corp. | 27.03M | 4.96% | 129,998 | - |
| 469 | NNVC | NanoViricides, Inc. | 26.99M | -3.85% | 124,819 | - |
| 470 | AEON | AEON Biopharma, Inc. | 26.57M | 0.96% | 29,204 | - |
| 471 | NRSN | NeuroSense Therapeutics Ltd. | 26.52M | 4.92% | 199,540 | - |
| 472 | NEUP | Neuphoria Therapeutics Inc. | 26.25M | -0.81% | 11,830 | 14.99M |
| 473 | TPST | Tempest Therapeutics, Inc. | 26.11M | 1.11% | 56,839 | - |
| 474 | PLRZ | Polyrizon Ltd. | 25.94M | -1.62% | 54,146 | - |
| 475 | CVM | CEL-SCI Corporation | 25.83M | -3.56% | 57,619 | - |
| 476 | BRNS | Barinthus Biotherapeutics plc | 24.59M | -5.79% | 4,602 | 14.97M |
| 477 | SER | Serina Therapeutics, Inc. | 24.14M | 1.03% | 36,002 | 130.00K |
| 478 | MRKR | Marker Therapeutics, Inc. | 23.34M | -3.45% | 72,035 | 3.55M |
| 479 | VTGN | Vistagen Therapeutics, Inc. | 23.34M | 3.33% | 335,532 | 789.00K |
| 480 | JSPR | Jasper Therapeutics, Inc. | 23.23M | -8.33% | 466,280 | - |
| 481 | LEXX | Lexaria Bioscience Corp. | 22.69M | -2.93% | 48,485 | 368.00K |
| 482 | CRIS | Curis, Inc. | 22.24M | -8.53% | 487,494 | 9.44M |
| 483 | QNCX | Quince Therapeutics, Inc. | 21.84M | -1.47% | 803,974 | - |
| 484 | OSRH | OSR Holdings, Inc. | 21.83M | 10.74% | 1,076,380 | 2.91M |
| 485 | VYNE | VYNE Therapeutics Inc. | 21.62M | 1.33% | 48,985 | 570.00K |
| 486 | NCEL | NewcelX Ltd. | 21.42M | -4.28% | 110,627 | - |
| 487 | ALLR | Allarity Therapeutics, Inc. | 21.36M | -3.57% | 54,966 | 320.00K |
| 488 | XCUR | Exicure, Inc. | 20.72M | -10.71% | 16,264 | 500.00K |
| 489 | COCP | Cocrystal Pharma, Inc. | 19.58M | 0.71% | 107,523 | - |
| 490 | PBM | Psyence Biomedical Ltd. | 18.92M | -8.64% | 1,158,361 | - |
| 491 | PASG | Passage Bio, Inc. | 18.77M | -0.85% | 43,810 | - |
| 492 | QNTM | Quantum BioPharma Ltd. | 18.49M | 10.12% | 163,694 | - |
| 493 | LPCN | Lipocine Inc. | 17.81M | 3.83% | 97,603 | 1.98M |
| 494 | KTTA | Pasithea Therapeutics Corp. | 17.21M | 0.09% | 104,508 | - |
| 495 | CTXR | Citius Pharmaceuticals, Inc. | 17.06M | -18.26% | 2,782,736 | 3.94M |
| 496 | TOVX | Theriva Biologics, Inc. | 16.96M | -2.99% | 5,785,932 | - |
| 497 | ICU | SeaStar Medical Holding Corporation | 16.65M | -1.65% | 112,122 | 1.23M |
| 498 | GNTA | Genenta Science S.p.A. | 16.56M | 0.01% | 40,285 | - |
| 499 | HIND | Vyome Holdings, Inc. | 15.58M | -1.77% | 34,078 | 319.71K |
| 500 | HOTH | Hoth Therapeutics, Inc. | 15.11M | -0.98% | 196,270 | - |